Moreover, it has been verified that reducing oxidative stress in cardiomyocytes alleviates the cardiotoxicity triggered by anti-tumor drugs, specifically by regulating the levels of ROS, MDA, SOD and GSH23. The gene discussed is SOD1; the disease is neoplasm.